112
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia

, , , , , , , , , , , & show all
Pages 967-970 | Received 17 Aug 2019, Accepted 19 Nov 2019, Published online: 06 Dec 2019
 

Acknowledgments

The authors thank Mr. Trevor Ralph for his English proofreading and Mr. Susumu Ito for his excellent technical assistance.

Author’s contributions

SSa and CT wrote the manuscript. CT and KM established and conducted the MRD analysis. SM performed flowcytometric analysis. SSa, RY, TS, KY, MT, KS, SSh, KK, and YN contributed to the patient’s care and acquired and analyzed patient data. RY and SSh performed emergency leukapheresis. KS and KK supervised the patient’s care. All authors critically revised the manuscript and have approved the final version.

Disclosure statement

The authors declare no conflicts of interest.

Additional information

Funding

This work was supported by the Japan Society for the Promotion of Science (JSPS KAKENHI grant number 21390308 provided to KK and 18K15702 provided to SSa).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.